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regions over 94% of the S. equi genome. A total of 253 genes were
identiﬁed as required for growth in standard laboratory condi-
tions, providing a blue-print for basic cell survival. Amongst
other ﬁndings, the 14 genes associated with the iron-seques-
tering molecule equibactin, were all found to be non-essential to
S. equi in vitro with the exception of the regulatory gene, eqbA.
This gene mediates iron uptake to prevent intracellular iron
toxicity, which is reﬂected by its importance in this study. To
reduce the impact of phage infections, bacteria have developed
‘cell suicide’ abortive infection mechanisms. In S. equi, the genes
encoding toxin production for abortive infection were found to
be non-essential, but a gene encoding an anti-toxin was
required. In a pilot study, a library of mutants was used to
determine if TraDIS is able to identify genes involved in the
interaction between S. equi and equine phagocytes (equine
macrophage-like cells (eCAS)). Mutants containing insertions in
11 genes involved in resistance to oxidative stress and into two
genes involved in capsule formation were reduced in ﬁtness. The
identiﬁcation of these genes highlights the importance of
maintaining both the capsule and the ability to resist oxidative
stress in S. equi, in the presence of eCAS. The ability of TraDIS to
simultaneously allocate importance to genes under particular
conditions makes it an attractive high-throughput method with
which to explore and build on current knowledge of the func-
tional genomics of S. equi to direct the design of safer and more
effective vaccines.
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Strangles, caused by Streptococcus equi (S. equi) is one of the
most frequently diagnosed infectious diseases of horses and
there remains a signiﬁcant need to develop new preventative
vaccines. We have previously reported that a live vaccine strain
based on S. equi strain 4047 (Se4047), which contained deletions
in six genes: sagA, hasA, aroB, pyrC, seM and recA, conferred
excellent levels of protection, but caused adverse reactions at the
intramuscular injection site in ﬁve of nine vaccinated ponies.
Here we describe the optimisation of a new live attenuated
vaccine against strangles. Emerging data from genome
sequencing projects identiﬁed that, in contrast to earlier data,
the population of S. equi is dynamic and constantly changing.
These data provide evidence that the currently available vaccines
against strangles, Pinnacle IN and Equilis StrepE, or those based
on the Se4047 strain, isolated from a diseased horse in the UK
during 1990, differ from the contemporary population of Euro-
pean strains by over 200 years in evolutionary time. Our analysis
identiﬁed variation in several surface components of the bacteria
that are likely to be targeted by the equine immune response
suggesting that an update of the current vaccines may improve
the protection conferred against natural cases of disease. Here
we report the generation of an updated live attenuated vaccine,
based on strain Se4592, which lacks components targeted by
modern diagnostic tests permitting the differentiation of infec-
ted from vaccinated animals (DIVA). In order to improve the
intramuscular safety of the Se4592 vaccine, we exploited a novel
transposon directed insertion-site sequencing (TraDIS) method
to identify genes required for the development of injection-siteabscesses. Our results provide an insight into S. equi infection
and a blueprint towards the design of safer and more effective
vaccines.
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An important concept is that effective control and ultimately
eradication of a disease within a given population only comes
with a thorough understanding of that disease’s behaviour in
that setting or put another way through good knowledge of the
epidemiology of that disease. Factors that are relevant to the
behaviour of a disease in a population include awareness of
sources of infection, routes of transmission, roles of sub-clinical
carriers and latent infections, biosecurity and hygiene, diagnostic
methods and performance and preventive measures including
use of vaccination. The past 20 years have seen considerable
strides taken in improving the means by which S. equi infections
and ‘strangles’, the disease that they cause, can be detected,
controlled and eradicated from groups of horses. These strides
include the recognition of the importance of subclinical carrier
animals and their ability to act as perpetual potential sources of
S. equi and the development and validation of improved di-
agnostics assays, including highly sensitive qPCR agent detection
methods and highly speciﬁc serological ELISAs with which to
evaluate horses’ immunological responses to S. equi. All of these
elements are now incorporated into internationally recognised
‘Strangles’ control, eradication and prevention protocols, such as
those outlined in the Horserace Betting Levy Board’s 2015 Codes
of Practice (http://codes.hblb.org.uk/index.php/page/99). How-
ever, there is a signiﬁcant missing element from the current
‘strangles’ control armoury in that S. equi vaccines with DIVA
capability are not yet available anywhere in the world e i.e.
products for which immunological responses following natural
infection can be meaningfully differentiated from those
following vaccination. Importantly work on two fronts at the
Animal Health Trust gives realistic prospects that in the rela-
tively near future different forms of DIVA vaccines (both subunit
and live attenuated) may become a reality. We propose that
when DIVA strangles vaccines are available they will provide the
biggest opportunity for effective control of S. equi infection and
‘strangles’. This will because for the ﬁrst time the joint ap-
proaches of infection eradication and vaccination can be mean-
ingfully joined without one compromising the other. This
presentation will provide a conceptual overview of how DIVA
vaccines may in future be effectively linked with currently
advocated disease control, eradication and prevention pro-
grammes. This will facilitate eradication of endemic infections
whilst safely maintaining herd immunity, differentiated for the
ﬁrst time between presumed trickling natural infection from
subclinically infected animals and that provided by DIVA vacci-
nation. In conclusion, all evidence suggests that healthy carriers
will remain critical in endemic persistence of ‘strangles’ and that
eradication by vaccination alone is unlikely to be effective. It has
been shown on individual premises at least that other control
measures can be effective in eradicating strangles from pop-
ulations of horses and maintaining them as disease free there-
after. Future DIVA vaccines will greatly enhance control of
‘strangles’ and its ultimate eradication.
